BamSEC and AlphaSense Join Forces
Learn More

InMed Pharmaceuticals Inc. – Indentures

NASDAQ: INM    
Share price (6/2/26): $1.52    
Market cap (6/2/26): $4.262 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.3
from 8-K 16 pages Placement Agent Preferred Investment Option InMed Pharmaceuticals Inc
12/34/56
EX-4.2
from 8-K 15 pages Preferred Investment Option InMed Pharmaceuticals Inc
12/34/56
EX-4.1
from 8-K 14 pages Pre-Funded Common Shares Purchase Warrant InMed Pharmaceuticals Inc
12/34/56
EX-4.13
from 10-K 1 page Description of Registrant’s Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.13
from 10-Q 1 page Description of Registrant’s Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from 8-K 18 pages Placement Agent Preferred Investment Option InMed Pharmaceuticals Inc
12/34/56
EX-4.2
from 8-K 18 pages Preferred Investment Option InMed Pharmaceuticals Inc
12/34/56
EX-4.1
from 8-K 18 pages Pre-Funded Common Shares Purchase Warrant InMed Pharmaceuticals Inc
12/34/56
EX-4.13
from 10-K 1 page Description of Registrant’s Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from 8-K 17 pages Placement Agent Preferred Investment Option InMed Pharmaceuticals Inc
12/34/56
EX-4.2
from 8-K 16 pages Preferred Investment Option InMed Pharmaceuticals Inc
12/34/56
EX-4.1
from 8-K 15 pages Pre-Funded Common Shares Purchase Warrant InMed Pharmaceuticals Inc
12/34/56
EX-4.13
from 10-K/A 1 page Description of Registrant’s Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from 8-K 18 pages Placement Agent Preferred Investment Option InMed Pharmaceuticals Inc
12/34/56
EX-4.2
from 8-K 18 pages Preferred Investment Option InMed Pharmaceuticals Inc
12/34/56
EX-4.1
from 8-K 18 pages Pre-Funded Common Shares Purchase Warrant InMed Pharmaceuticals Inc
12/34/56
EX-4.4
from 8-K 2 pages Holder of Warrants to Purchase Common Shares Issued on November 16, 2020 and July 2, 2021 Re: Amendment to Existing Warrants Dear Holder: Reference Is Hereby Made to the Offering on or About the Date Hereof (The “Offering”) by InMed Pharmaceuticals Inc. (The “Company”) of Its Common Shares, Without Par Value (“Common Shares”) (Collectively, the “Shares”)
12/34/56
EX-4.3
from 8-K 16 pages Pre-Funded Common Shares Purchase Warrant InMed Pharmaceuticals Inc
12/34/56
EX-4.2
from 8-K 14 pages Pre-Funded Common Shares Purchase Warrant InMed Pharmaceuticals Inc
12/34/56
EX-4.1
from 8-K 16 pages Preferred Investment Option InMed Pharmaceuticals Inc
12/34/56